DK3244911T3 - Fremgangsmåde til bestemmelse af en sandsynlig virkning af en behandling til forbedring af mandlig ufrugtbarhed - Google Patents

Fremgangsmåde til bestemmelse af en sandsynlig virkning af en behandling til forbedring af mandlig ufrugtbarhed Download PDF

Info

Publication number
DK3244911T3
DK3244911T3 DK16700794.7T DK16700794T DK3244911T3 DK 3244911 T3 DK3244911 T3 DK 3244911T3 DK 16700794 T DK16700794 T DK 16700794T DK 3244911 T3 DK3244911 T3 DK 3244911T3
Authority
DK
Denmark
Prior art keywords
procedure
determining
treatment
effect
male fertility
Prior art date
Application number
DK16700794.7T
Other languages
English (en)
Inventor
Martin Blomberg Jensen
Original Assignee
Rigshospitalet Copenhagen Univ Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rigshospitalet Copenhagen Univ Hospital filed Critical Rigshospitalet Copenhagen Univ Hospital
Application granted granted Critical
Publication of DK3244911T3 publication Critical patent/DK3244911T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/29—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1825—Fibroblast growth factor [FGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2875—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the NGF/TNF superfamily, e.g. CD70, CD95L, CD153, CD154

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
DK16700794.7T 2015-01-12 2016-01-08 Fremgangsmåde til bestemmelse af en sandsynlig virkning af en behandling til forbedring af mandlig ufrugtbarhed DK3244911T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA201570010 2015-01-12
PCT/DK2016/050005 WO2016112916A1 (en) 2015-01-12 2016-01-08 Antibodies, compounds and derivatives thereof for use in the treatment of male infertility

Publications (1)

Publication Number Publication Date
DK3244911T3 true DK3244911T3 (da) 2019-12-16

Family

ID=55173722

Family Applications (1)

Application Number Title Priority Date Filing Date
DK16700794.7T DK3244911T3 (da) 2015-01-12 2016-01-08 Fremgangsmåde til bestemmelse af en sandsynlig virkning af en behandling til forbedring af mandlig ufrugtbarhed

Country Status (3)

Country Link
EP (1) EP3244911B1 (da)
DK (1) DK3244911T3 (da)
WO (1) WO2016112916A1 (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021121525A1 (en) 2019-12-18 2021-06-24 Fertilitypro Aps Rankl, opg and rank as seminal biomarkers for male infertility
WO2022002336A1 (en) 2020-07-03 2022-01-06 Fertilitypro Aps Amh and/or inhibin b as a biomarker for an effect of a treatment to improve male fertility
EP4260069A1 (en) 2020-12-08 2023-10-18 Rigshospitalet Method for predicting the fertility potential of a female subject

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4411993A (en) 1981-04-29 1983-10-25 Steven Gillis Hybridoma antibody which inhibits interleukin 2 activity
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4703004A (en) 1984-01-24 1987-10-27 Immunex Corporation Synthesis of protein with an identification peptide
WO1988001649A1 (en) 1986-09-02 1988-03-10 Genex Corporation Single polypeptide chain binding molecules
US5260203A (en) 1986-09-02 1993-11-09 Enzon, Inc. Single polypeptide chain binding molecules
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
JP5566026B2 (ja) * 2005-08-18 2014-08-06 ディーエスエム アイピー アセッツ ビー．ブイ． 動物の雄の生殖能力を改善するための２５−ヒドロキシビタミンｄ３の使用
CA2854372A1 (en) 2011-11-07 2013-05-16 Universite Laval Use of rank/rankl antagonists for treating neuromuscular disorders, genetic myopathies and/or non genetic myopathies and/or for regulating skeletal and cardiac muscle disuse, diseases and aging
WO2015018421A1 (en) * 2013-08-07 2015-02-12 Rigshospitalet Copenhagen University Hospital Antibodies, compounds and derivatives thereof for use in the treatment of male infertility

Also Published As

Publication number Publication date
EP3244911A1 (en) 2017-11-22
EP3244911B1 (en) 2019-10-23
WO2016112916A1 (en) 2016-07-21

Similar Documents

Publication Publication Date Title
DK3371171T3 (da) Inhibitorer af RET
DK3192902T3 (da) Fremgangsmåde til fremstilling af graphenholdige viscosefibre
DK3785717T3 (da) Fremgangsmåder til behandling af coronaviridae-infektioner
DK3286311T3 (da) Fremgangsmåde til behandling af maligniteter
DK3160956T3 (da) Inhibitorer af lysin-specifik demethylase-1
DK3102576T3 (da) Dihydropyrrolopyridininhibitorer af ror-gamma
DK3096741T3 (da) Fremgangsmåde til fremstillingen af hybridosomer
DK3166976T3 (da) Anti-pd-l1-kombinationer til behandling af tumorer
DK3072835T3 (da) Fremgangsmåde til fremføring
DK3851537T3 (da) Behandling af hyperbilirubinæmi
DK3511319T3 (da) Hæmmere af lysinspecifik demethylase-1
DK3325443T3 (da) Fremgangsmåde til fremstilling af pridopidin
DK3174858T3 (da) Fremgangsmåde til fremstilling af pyrazoler
DK3466432T3 (da) Fremgangsmåder til behandling af pulmonale non-tuberkuløse mykobakterielle infektioner
DK3317400T3 (da) Fremgangsmåde til kryokonservering af tumorinfiltrerende lymfocytter
DK3240612T3 (da) Fremgangsmåder til behandling af nethindesygdomme
BR112017000042A2 (pt) inibidores de desmetilase-1 lisina-específica
DK3371165T3 (da) Btk-inhibitor til anvendelse til behandling af kræft
DK3265087T3 (da) Fremgangsmåde til behandling med tradipitant
DK3318115T3 (da) Maskine til behandling af svinegylle
DK3229995T3 (da) Fremgangsmåde for fremstilling af et endestykke
DK3164394T3 (da) Gls1-inhibitorer til behandling af sygdomme
DK3277915T3 (da) Fremgangsmåde til nedlukning af en brøn
DK3280408T3 (da) Fremgangsmåde til fremstilling af dicycloplatin
DK3204352T3 (da) Hæmmere af lysin-gingipain